Capvizr
THE DEAL, AT A GLANCE

Profluent Bio

From the announcement
01Who is involvedBacked by Salesforce, VariousFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedProfluent Bio raised $35M Series AFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersProfluent Bio is positioned around an AI protein language model that designs novel enzymes and functional proteins from text prompts, with Series A capital directed…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Profluent Bio · Financing Record

Explore source-linked visual explanations for Profluent Bio. Unsupported claims are withheld while source review continues.

Record 864 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 864 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime